Targeted Delivery of NGF-Pretreated Schwann Cell-Derived Exosomes for Osteoporosis Therapy: Overcoming Pain while Enhancing Bone Formation
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.6c00906 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Yinnan Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Cellular Physiology, and Department of Physiology, Shanxi Medical University, Taiyuan030001, China. Hauptthemen laut MEDLINE: Nerve Growth Factor, Osteoporosis, Exosomes, Schwann Cells. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Osteoporosis (OP) is a prevalent skeletal disorder characterized by decreased bone mass and increased fragility, leading to fractures and chronic pain. Nerve growth factor (NGF) plays a pivotal role in bone homeostasis and neuro-regeneration but paradoxically exacerbates pain. This study investigated the therapeutic potential of engineered, bone-targeting exosomes derived from NGF-pretreated Schwann cells (NGF-Exo-Pep) for the treatment of OP. We demonstrated that NGF-Exo-Pep effectively promoted osteogenic differentiation and mineralization of bone marrow mesenchymal stem cells (BMSCs) in vitro, while also enhancing Schwann cell proliferation, migration, and neurotrophic factor secretion. Mechanistically, miRNA sequencing revealed that NGF-Exo-Pep was enriched in osteogenic miRNAs. In vivo, NGF-Exo-Pep treatment in ovariectomized mice significantly improved bone microarchitecture, increased osteoblast activity, reduced osteoclast activity, and neurotization of bone tissue. Notably, NGF-Exo-Pep alleviated pain-related behaviors by downregulating pain mediators and reducing c-Fos expression in the spinal cord. This study presented a novel and promising strategy for OP treatment, harnessing the pro-regenerative properties of NGF while mitigating its pain-inducing side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Cellular Physiology, and Department of Physiology, Shanxi Medical University, Taiyuan030001, China.
- Department of Pain Medicine, Shanxi Provincial People's Hospital, No. 29 Shuangtasi Street, Taiyuan, Shanxi030001, China.
- Department of Radiology, Second hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi030001, China.
- Department of Orthopedic Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an710000, China.
- Department of Physiology, School of Basic Medical Sciences, Shanxi Medical University, No. 56 Xinjian South Road, Taiyuan030001, China.
ORCID-Profile: Xiangying Jiao
Förderung
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Guo, Y., Cui, S., Zhang, W., Wu, Y., Song, Q., Chang, L., & Jiao, X. (2026). Targeted Delivery of NGF-Pretreated Schwann Cell-Derived Exosomes for Osteoporosis Therapy: Overcoming Pain while Enhancing Bone Formation. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.6c00906
Vancouver
Guo Y, Cui S, Zhang W, Wu Y, Song Q, Chang L, et al. Targeted Delivery of NGF-Pretreated Schwann Cell-Derived Exosomes for Osteoporosis Therapy: Overcoming Pain while Enhancing Bone Formation. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.6c00906
BibTeX
@article{Guo2026,
author = {Guo, Yinnan and Cui, Sha and Zhang, Wenting and Wu, Yali and Song, Qi and Chang, Le and Jiao, Xiangying},
title = {Targeted Delivery of NGF-Pretreated Schwann Cell-Derived Exosomes for Osteoporosis Therapy: Overcoming Pain while Enhancing Bone Formation},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.6c00906}
}
EUVIMED